Leadership Overview
EXALTA has 4 executives leading key functions including financial strategy, technological innovation, human capital management, and corporate governance.
Focused on advancing clinical outcomes through medical device manufacturing, EXALTA delivers comprehensive solutions to healthcare providers while maintaining a commitment to improving patient care across the global medical technology sector.
Focused on advancing clinical outcomes through medical device manufacturing, EXALTA delivers comprehensive solutions to healthcare providers while maintaining a commitment to improving patient care across the global medical technology sector.
Leadership Roles at EXALTA
Damien Sibilla - Chief Financial Officer
Damien Sibilla, the Chief Financial Officer at EXALTA, directs all fiscal operations and capital allocation strategies for the organization. Managing the financial health of the medical device manufacturing portfolio, the Chief Financial Officer ensures alignment between investment in research and development and long-term revenue growth. Sibilla oversees the integration of financial systems following the merger of Tyber Medical, Intech, and Resolve Surgical to optimize operational efficiency. By monitoring market trends across North American and international healthcare sectors, the Chief Financial Officer provides the necessary data to support strategic expansion. Damien Sibilla maintains rigorous oversight of budgetary compliance and risk management protocols to protect the company's assets. Through precise financial modeling and resource management, the Chief Financial Officer enables the business to scale production capabilities effectively. This leadership role remains vital for sustaining the financial stability required to advance clinical outcomes and deliver innovative MedTech solutions to the global market.
Jeffrey Tyber - Group President and Board Member
Jeffrey Tyber, the Group President and Board Member at EXALTA, provides executive leadership and strategic direction for the entire medical technology enterprise. Overseeing the long-term vision of the company, the Group President and Board Member ensures that the organization remains focused on its core mission of improving patient care through innovative manufacturing. Tyber facilitates communication between the board and the executive team to maintain alignment on corporate objectives and market expansion. By leveraging deep industry expertise, the Group President and Board Member guides the company through the complexities of the medical device manufacturing sector. Jeffrey Tyber monitors the competitive landscape to identify opportunities for growth and strategic partnerships that enhance the product portfolio. This role involves setting the tone for corporate governance and ensuring that all business activities adhere to the highest ethical standards. Through consistent leadership, the Group President and Board Member drives the company toward achieving its goal of delivering comprehensive, high-quality medical solutions to healthcare providers worldwide.
David Hannah - Chief Technology Officer
David Hannah, the Chief Technology Officer at EXALTA, architects the technical roadmap for the development and manufacturing of advanced medical devices. Overseeing the engineering teams, the Chief Technology Officer drives innovation in surgical technologies to improve patient care outcomes. Hannah integrates the diverse product portfolios of the founding organizations into a cohesive, high-performance manufacturing framework. By collaborating with clinical experts, the Chief Technology Officer ensures that every new device meets the highest standards of medical precision and safety. David Hannah manages the research and development pipeline to maintain a competitive edge in the medical device manufacturing sector. This role involves identifying emerging technologies that enhance surgical procedures and medical treatments for healthcare providers. Through the implementation of cutting-edge manufacturing processes, the Chief Technology Officer supports the company's mission to provide comprehensive solutions. Hannah consistently pushes the boundaries of MedTech to ensure that the organization remains at the forefront of clinical innovation.
DenaRae Walter - Chief People Officer
DenaRae Walter, the Chief People Officer at EXALTA, directs the human capital strategy and organizational culture for the medical technology firm. Managing talent acquisition and professional development, the Chief People Officer ensures that the workforce possesses the specialized skills required for complex medical device manufacturing. Walter oversees the integration of diverse teams from the founding organizations to foster a unified corporate identity. By implementing robust performance management systems, the Chief People Officer aligns individual contributions with the broader mission of advancing clinical outcomes. DenaRae Walter designs programs that promote employee engagement and retention across all operational regions. This leadership role involves cultivating an environment of innovation and excellence that attracts top talent in the MedTech industry. Through strategic workforce planning, the Chief People Officer supports the company's ability to scale operations and meet the evolving needs of healthcare providers. Walter maintains a focus on building a resilient, high-performing organization capable of delivering superior medical solutions.
Explore Leadership Teams in Manufacturing
Enovis is a global medical technology innovator focused on improving lives by creating clinically differentiated solutions that help restore motion and enhance patient outcomes. The company partners with leading experts in healthcare to advance smarter, personalized, and more effective care while supporting the operational needs of surgeons and clinicians. Driven by a culture of continuous improvement, innovation, and strategic growth, Enovis offers a broad portfolio of products, services, and integrated technologies, including well-known brands that support patients throughout their journey to better health.
Company Leadership
OE
JM
Accuray develops and manufactures advanced radiation oncology systems designed to deliver precise cancer treatment solutions. The company specializes in creating innovative medical devices that enable clinicians to target tumors with exceptional accuracy while minimizing exposure to surrounding healthy tissue. This focus on precision has shaped the organization's technical approach and product development strategy across its portfolio. The company's radiation oncology systems integrate sophisticated imaging, planning, and delivery technologies to support comprehensive cancer care. By combining real-time imaging capabilities with adaptive treatment planning, Accuray's platforms allow medical teams to adjust therapy in response to anatomical changes during treatment courses. This technological integration addresses a critical challenge in oncology: maintaining treatment efficacy while reducing potential side effects that can impact patient quality of life. Accuray serves hospitals, cancer treatment centers, and specialized radiation oncology facilities globally. The company's systems support treatment of various cancer types across different anatomical sites, from brain and head-and-neck tumors to thoracic and abdominal malignancies. Healthcare providers rely on Accuray's technology to expand their treatment capabilities and improve clinical outcomes for patients who might otherwise have limited options.
Company Leadership MR
ROMTech® is thrilled to present our patented and groundbreaking rehabilitation technology, designed to serve a variety of orthopedic indications. Our revolutionary technology is improving patient outcomes, cutting cost of care, and overhauling the way postoperative orthopedic care is delivered.
Company Leadership
PL
GE
MR
Inogen, headquartered in Goleta, California, and established in 2001, is a medical technology company that develops and manufactures portable oxygen concentrators that provide supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions.
Company Leadership
BT
Frequently Asked Questions Regarding EXALTA Top Executives and Leadership Team
